Results 241 to 250 of about 883,694 (328)

In a quest for better outcome prediction in cardiogenic shock

ESC Heart Failure, Volume 12, Issue 3, Page 1539-1540, June 2025.
Wiktor Kuliczkowski
wiley   +1 more source

Lactate orchestrates metabolic hemodynamic adaptations through a unique combination of venocontraction, artery relaxation, and positive inotropy

Acta Physiologica, Volume 241, Issue 5, May 2025.
Abstract Aim H+ facilitates metabolic blood flow regulation while negatively impacting cardiac contractility. Cardiovascular consequences of conjugate bases accumulating alongside H+ remain unclear. Here, we evaluate the cardiovascular effects of nine prominent carboxylates—particularly lactate, 3‐hydroxybutyrate, and butyrate—linked to metabolic and ...
Casper Homilius, Jacob M. Seefeldt, Jakob Hansen, Roni Nielsen, Frank V. de Paoli, Ebbe Boedtkjer   +5 more
wiley   +1 more source

Accuracy of early shock recognition by paramedics: a multicenter prospective observational study in Japan. [PDF]

J Rural Med
Tanohata R, Saito K, Nagano T, Ochiai H.
europepmc   +1 more source

Insulin and Cardiogenic Shock [PDF]

BMJ, 1969
openaire   +3 more sources

Impact of COVID‐19 on long‐term outcomes in Parkinson's disease

European Journal of Neurology, Volume 32, Issue 5, May 2025.
Abstract Objectives Patients with pre‐existing Parkinson's disease (PD) face higher risks of severe acute COVID‐19 outcomes than matched controls, but long‐term post‐COVID‐19 outcomes remain largely unknown. This study investigated clinical outcomes up to 3.5 years post‐infection in a Bronx inner‐city PD population.
Roham Hadidchi, Yousef Al‐Ani, Hannah Piskun, Rachel Pakan, Katie S. Duong, Hasan Jamil, Stephen H. Wang, Sonya Henry, Carine W. Maurer, Tim Q. Duong   +9 more
wiley   +1 more source

Extracorporeal Membrane Oxygenation-Impella (ECPELLA) for Sepsis-Induced Cardiogenic Shock: A Case Report on Vascular Access Selection and Its Use Without Systemic Anticoagulation. [PDF]

Cureus
Serizawa H, Suzuki G, Kobori T, Nakamichi Y, Honda M.   +4 more
europepmc   +1 more source

Clinical Outcomes of Mitral Valve Repair in Dogs With Pulmonary Hypertension Secondary to Myxomatous Mitral Valve Disease

Journal of Veterinary Internal Medicine, Volume 39, Issue 3, May/June 2025.
ABSTRACT Background Myxomatous mitral valve disease (MMVD) can cause pulmonary hypertension (PH). Mitral valve repair (MVR) has been described as a surgical treatment option for MMVD, but the benefit of MVR when PH is present is unknown. Hypothesis/Objectives To investigate the change in echocardiographic variables and long‐term outcomes of dogs with ...
Tomohiko Yoshida, Darcy Adin, Katsuhiro Matsuura   +2 more
wiley   +1 more source

The golden ratio in the pulmonary circulation in patients with heart failure and cardiogenic shock. [PDF]

Physiol Rep
Lim HS, Yim IHW.
europepmc   +1 more source

Expanding beyond trauma: Characterizing low titer group O whole blood (LTOWB) use in children requiring massive transfusion protocol activation

Transfusion, Volume 65, Issue S1, Page S173-S180, May 2025.
Abstract Introduction Data regarding low titer group O whole blood (LTOWB) use for hemostatic resuscitation is largely derived from trauma cohorts; studies regarding its use in uninjured pediatric patients are lacking. Methods The blood bank database from a single academic pediatric hospital with a massive transfusion protocol (MTP) allowing the use of
Erin V. Feeney, Elissa Abou Khalil, Barbara A. Gaines, Philip C. Spinella, Christine M. Leeper   +4 more
wiley   +1 more source

The current use of vasoactive agents in cardiogenic shock related to myocardial infarction and acute decompensated heart failure. [PDF]

Am Heart J Plus
Becerra AF, Amanamba U, Lopez JE, Blaker NJ, Winchester DE.   +4 more
europepmc   +1 more source